These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 17366928

  • 1. Chemotherapy-induced nausea and vomiting: clinician and patient perspectives.
    Schwartzberg LS.
    J Support Oncol; 2007 Feb; 5(2 Suppl 1):5-12. PubMed ID: 17366928
    [Abstract] [Full Text] [Related]

  • 2. Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.
    Navari RM.
    J Support Oncol; 2003 Feb; 1(2):89-103. PubMed ID: 15352652
    [Abstract] [Full Text] [Related]

  • 3. Chemotherapy-induced nausea and vomiting.
    Lohr L.
    Cancer J; 2008 Feb; 14(2):85-93. PubMed ID: 18391612
    [Abstract] [Full Text] [Related]

  • 4. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis.
    Slatkin NE.
    J Support Oncol; 2007 May; 5(5 Suppl 3):1-9. PubMed ID: 17566383
    [Abstract] [Full Text] [Related]

  • 5. Palonosetron: a second generation 5-hydroxytryptamine 3 receptor antagonist.
    Navari RM.
    Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1577-86. PubMed ID: 19929251
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting.
    Hajdenberg J, Grote T, Yee L, Arevalo-Araujo R, Latimer LA.
    J Support Oncol; 2006 Oct; 4(9):467-71. PubMed ID: 17080735
    [Abstract] [Full Text] [Related]

  • 9. Palonosetron versus other 5-HT(3) receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with cancer on chemotherapy in a hospital outpatient setting.
    Balu S, Buchner D, Craver C, Gayle J.
    Clin Ther; 2011 Apr; 33(4):443-55. PubMed ID: 21635990
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chemotherapy-induced nausea and vomiting in the treatment of gastrointestinal tumors and secondary prophylaxis with aprepitant.
    Abbrederis K, Lorenzen S, Rothling N, Ihbe-Heffinger A, Schuster T, Peschel C, Lordick F.
    Onkologie; 2009 Feb; 32(1-2):30-4. PubMed ID: 19209016
    [Abstract] [Full Text] [Related]

  • 12. [Croatian guideliness for prevention of chemotherapy induced nausea and vomiting].
    Tomek R, Vrdoljak E, Vrbanec D, Nemet D, Matković V, Plestina S, Gugić D, Dintinjana RD, Bolanca A, Samarzija M, Petković M.
    Lijec Vjesn; 2009 Feb; 131(3-4):49-53. PubMed ID: 19514248
    [Abstract] [Full Text] [Related]

  • 13. Chemotherapy-induced nausea and vomiting: state of the art in 2006.
    Schwartzberg L.
    J Support Oncol; 2006 Feb; 4(2 Suppl 1):3-8. PubMed ID: 16499138
    [Abstract] [Full Text] [Related]

  • 14. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W, Mo FK, Suen JJ, Ho WM, Chan SL, Lau W, Koh J, Yeung WK, Kwan WH, Lee KK, Mok TS, Poon AN, Lam KC, Hui EK, Zee B.
    Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aprepitant: a novel antiemetic for chemotherapy-induced nausea and vomiting.
    Massaro AM, Lenz KL.
    Ann Pharmacother; 2005 Jan; 39(1):77-85. PubMed ID: 15562136
    [Abstract] [Full Text] [Related]

  • 17. Best practice management of CINV in oncology patients: II. Antiemetic guidelines and rationale for use.
    Wickham R.
    J Support Oncol; 2010 Jan; 8(2 Suppl 1):10-5. PubMed ID: 20629453
    [Abstract] [Full Text] [Related]

  • 18. Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting.
    Navari RM.
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):715-24. PubMed ID: 15485308
    [Abstract] [Full Text] [Related]

  • 19. Chemotherapy-induced nausea and vomiting: prevention, detection, and treatment--how are we doing?
    Grunberg SM.
    J Support Oncol; 2004 Oct; 2(1 Suppl 1):1-10, inside back cover; quiz 11. PubMed ID: 16117016
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.